nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—Sialoadenitis—Hydrochlorothiazide—nephrolithiasis	0.045	0.0529	CcSEcCtD
Delavirdine—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0271	CcSEcCtD
Delavirdine—CYP2C19—urine—nephrolithiasis	0.0225	0.15	CbGeAlD
Delavirdine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0246	CcSEcCtD
Delavirdine—CYP1A2—urine—nephrolithiasis	0.0184	0.122	CbGeAlD
Delavirdine—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0181	0.0212	CcSEcCtD
Delavirdine—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0179	0.021	CcSEcCtD
Delavirdine—CYP2C9—urine—nephrolithiasis	0.0174	0.116	CbGeAlD
Delavirdine—CYP3A4—urine—nephrolithiasis	0.0133	0.0886	CbGeAlD
Delavirdine—CYP2D6—urine—nephrolithiasis	0.0131	0.0872	CbGeAlD
Delavirdine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0146	CcSEcCtD
Delavirdine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0144	CcSEcCtD
Delavirdine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0143	CcSEcCtD
Delavirdine—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0139	CcSEcCtD
Delavirdine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0139	CcSEcCtD
Delavirdine—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.0115	0.0768	CbGeAlD
Delavirdine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0135	CcSEcCtD
Delavirdine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0132	CcSEcCtD
Delavirdine—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0132	CcSEcCtD
Delavirdine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0127	CcSEcCtD
Delavirdine—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.01	0.0118	CcSEcCtD
Delavirdine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00993	0.0117	CcSEcCtD
Delavirdine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00993	0.0117	CcSEcCtD
Delavirdine—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00985	0.0657	CbGeAlD
Delavirdine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00908	0.0107	CcSEcCtD
Delavirdine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00904	0.0106	CcSEcCtD
Delavirdine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00899	0.0106	CcSEcCtD
Delavirdine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00891	0.0105	CcSEcCtD
Delavirdine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00883	0.0104	CcSEcCtD
Delavirdine—Injury—Hydrochlorothiazide—nephrolithiasis	0.00867	0.0102	CcSEcCtD
Delavirdine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0086	0.0101	CcSEcCtD
Delavirdine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00849	0.00998	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00845	0.00994	CcSEcCtD
Delavirdine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00985	CcSEcCtD
Delavirdine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00827	0.00973	CcSEcCtD
Delavirdine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0082	0.00965	CcSEcCtD
Delavirdine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.008	0.00942	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00797	0.00938	CcSEcCtD
Delavirdine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0093	CcSEcCtD
Delavirdine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00923	CcSEcCtD
Delavirdine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00923	CcSEcCtD
Delavirdine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00755	0.00888	CcSEcCtD
Delavirdine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00747	0.00879	CcSEcCtD
Delavirdine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00731	0.0086	CcSEcCtD
Delavirdine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00857	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00845	CcSEcCtD
Delavirdine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00845	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00845	CcSEcCtD
Delavirdine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00706	0.0083	CcSEcCtD
Delavirdine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00827	CcSEcCtD
Delavirdine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00816	CcSEcCtD
Delavirdine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00811	CcSEcCtD
Delavirdine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00811	CcSEcCtD
Delavirdine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00795	CcSEcCtD
Delavirdine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00758	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00753	CcSEcCtD
Delavirdine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00635	0.00747	CcSEcCtD
Delavirdine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00738	CcSEcCtD
Delavirdine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00731	CcSEcCtD
Delavirdine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00727	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00717	CcSEcCtD
Delavirdine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00708	CcSEcCtD
Delavirdine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00704	CcSEcCtD
Delavirdine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00703	CcSEcCtD
Delavirdine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00703	CcSEcCtD
Delavirdine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00586	0.00689	CcSEcCtD
Delavirdine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00682	CcSEcCtD
Delavirdine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00678	CcSEcCtD
Delavirdine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00561	0.0066	CcSEcCtD
Delavirdine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00553	0.0065	CcSEcCtD
Delavirdine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00649	CcSEcCtD
Delavirdine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00646	CcSEcCtD
Delavirdine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00644	CcSEcCtD
Delavirdine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00639	CcSEcCtD
Delavirdine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00613	CcSEcCtD
Delavirdine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00605	CcSEcCtD
Delavirdine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00573	CcSEcCtD
Delavirdine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00565	CcSEcCtD
Delavirdine—CYP2C8—renal system—nephrolithiasis	0.0048	0.032	CbGeAlD
Delavirdine—CYP3A5—nephron tubule—nephrolithiasis	0.00476	0.0318	CbGeAlD
Delavirdine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00557	CcSEcCtD
Delavirdine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00554	CcSEcCtD
Delavirdine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00553	CcSEcCtD
Delavirdine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00549	CcSEcCtD
Delavirdine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00546	CcSEcCtD
Delavirdine—CYP2C8—kidney—nephrolithiasis	0.00464	0.0309	CbGeAlD
Delavirdine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00543	CcSEcCtD
Delavirdine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00532	CcSEcCtD
Delavirdine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00529	CcSEcCtD
Delavirdine—CYP1A2—renal system—nephrolithiasis	0.00449	0.0299	CbGeAlD
Delavirdine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00524	CcSEcCtD
Delavirdine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00522	CcSEcCtD
Delavirdine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00519	CcSEcCtD
Delavirdine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00516	CcSEcCtD
Delavirdine—CYP3A5—renal system—nephrolithiasis	0.00433	0.0289	CbGeAlD
Delavirdine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00509	CcSEcCtD
Delavirdine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00507	CcSEcCtD
Delavirdine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00506	CcSEcCtD
Delavirdine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00506	CcSEcCtD
Delavirdine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00499	CcSEcCtD
Delavirdine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00496	CcSEcCtD
Delavirdine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00493	CcSEcCtD
Delavirdine—CYP3A5—kidney—nephrolithiasis	0.00419	0.0279	CbGeAlD
Delavirdine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00481	CcSEcCtD
Delavirdine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00481	CcSEcCtD
Delavirdine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00481	CcSEcCtD
Delavirdine—CYP3A5—cortex of kidney—nephrolithiasis	0.00408	0.0272	CbGeAlD
Delavirdine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00479	CcSEcCtD
Delavirdine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00475	CcSEcCtD
Delavirdine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.004	0.0047	CcSEcCtD
Delavirdine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00465	CcSEcCtD
Delavirdine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00461	CcSEcCtD
Delavirdine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00453	CcSEcCtD
Delavirdine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00451	CcSEcCtD
Delavirdine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00382	0.0045	CcSEcCtD
Delavirdine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00446	CcSEcCtD
Delavirdine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00439	CcSEcCtD
Delavirdine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00366	0.00431	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0042	CcSEcCtD
Delavirdine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00417	CcSEcCtD
Delavirdine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00414	CcSEcCtD
Delavirdine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00411	CcSEcCtD
Delavirdine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00348	0.0041	CcSEcCtD
Delavirdine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00406	CcSEcCtD
Delavirdine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00401	CcSEcCtD
Delavirdine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00397	CcSEcCtD
Delavirdine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00394	CcSEcCtD
Delavirdine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00394	CcSEcCtD
Delavirdine—CYP3A4—renal system—nephrolithiasis	0.00325	0.0217	CbGeAlD
Delavirdine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0038	CcSEcCtD
Delavirdine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00377	CcSEcCtD
Delavirdine—CYP2D6—renal system—nephrolithiasis	0.0032	0.0213	CbGeAlD
Delavirdine—CYP3A4—kidney—nephrolithiasis	0.00314	0.021	CbGeAlD
Delavirdine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00366	CcSEcCtD
Delavirdine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00364	CcSEcCtD
Delavirdine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00364	CcSEcCtD
Delavirdine—CYP2D6—kidney—nephrolithiasis	0.00309	0.0206	CbGeAlD
Delavirdine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00289	0.0034	CcSEcCtD
Delavirdine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00281	0.00331	CcSEcCtD
Delavirdine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00326	CcSEcCtD
Delavirdine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00315	CcSEcCtD
Delavirdine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00305	CcSEcCtD
Delavirdine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00293	CcSEcCtD
Delavirdine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00291	CcSEcCtD
Delavirdine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0029	CcSEcCtD
Delavirdine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00289	CcSEcCtD
Delavirdine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00274	CcSEcCtD
